Fig. 1From: Central effects of galcanezumab in migraine: a pilot study on Steady State Visual Evoked Potentials and occipital hemodynamic response in migraine patientsfNIRS monitoring with 16 channels in parieto-occipital area. The red circles indicate sources. The blue circles represent detectorsBack to article page